BioNutri AR-1,
Dietary Supplementintervention with fermented and nutritionally balanced food twice a day
NCT Number: NCT06545149
Abstract: Studies demonstrate that the use of nutritional supplements containing beta-glucans stimulates the immune system, modulates inflammatory activity, and promotes so-called immune training. Beta-glucans are prebiotics that stimulate the growth and activity of gastrointestinal microbiota and inhibit pathogen growth. Nutritional intervention is crucial for patients' positive evolution, and providing a supplement with highly bioavailable nutrients can make a difference in their nutritional, metabolic, and immune status. Therefore, the study aims to verify the effectiveness of the innate and adaptive immune response to a nutritionally balanced fermented food, containing oral or enteral beta-glucans, in patients treated at 3 Emergency Care Units in São José do Rio Preto, São Paulo, Brazil. This is a prospective randomized study with a characteristic design involving patients treated in the medical wards of 3 Emergency Care Unit. The following assessments will be conducted: Global Subjective Assessment for adults and Mini Nutritional Assessment for the elderly, Sociodemographic, and Laboratory Evaluation.
Trial opening soon.
Get Notified18 year–100 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients admitted to the medical clinic ward
Exclusion criteria
Patients unable to swallow
intervention with fermented and nutritionally balanced food twice a day
Time frame: during hospitalization
Time frame: up to 24 weeks
Time frame: up to 24 weeks
Contact information is provided by the study sponsor or research team.
Federal University of São Paulo
Other
SUPPLEMENTATION WITH FERMENTED AND BALANCED FOOD WITH BETA GLUCAN FAVORS THE INNATE AND ADAPTATIVE RESPONSE OF PATIENTS ADMITTED TO A MEDICAL CLINIC WARD? A RANDOMIZED TRIAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06941753
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07737977
ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis
Montpellier, Occitanie, France
View Trial DetailsNCT07674745
Disease Attributes, Disease Progression
Birmingham, Alabama, United States
View Trial DetailsNCT07641699
Asymptomatic Degenerative Cervical Cord Compression, Cervical Spinal Cord Compression
Beijing, Beijing Municipality, China
View Trial Details